Northern Trust
KYMR icon

Northern Trust’s Kymera Therapeutics KYMR Stock Holding History

Northern Trust’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.7M Buy
581,907
+87,468
+18% +$7.52M 0.01% 1022
2026
Q1 		$41.2M Buy
494,439
+27,417
+6% +$2.17M 0.01% 1224
2025
Q4 		$36.3M Buy
467,022
+29,902
+7% +$2.02M ﹤0.01% 1306
2025
Q3 		$24.7M Buy
437,120
+27,767
+7% +$1.25M ﹤0.01% 1545
2025
Q2 		$17.9M Sell
409,353
-12,307
-3% -$424K ﹤0.01% 1711
2025
Q1 		$11.5M Sell
421,660
-16,173
-4% -$590K ﹤0.01% 1956
2024
Q4 		$17.6M Buy
437,833
+53,658
+14% +$2.42M ﹤0.01% 1777
2024
Q3 		$18.2M Buy
384,175
+16,034
+4% +$708K ﹤0.01% 1677
2024
Q2 		$11M Sell
368,141
-4,645
-1% -$161K ﹤0.01% 1938
2024
Q1 		$15M Buy
372,786
+14,207
+4% +$508K ﹤0.01% 1795
2023
Q4 		$9.13M Sell
358,579
-7,676
-2% -$137K ﹤0.01% 2134
2023
Q3 		$5.09M Buy
366,255
+11,327
+3% +$228K ﹤0.01% 2433
2023
Q2 		$8.16M Buy
354,928
+18,101
+5% +$519K ﹤0.01% 2210
2023
Q1 		$9.98M Sell
336,827
-4,614
-1% -$149K ﹤0.01% 2014
2022
Q4 		$8.52M Buy
341,441
+9,703
+3% +$259K ﹤0.01% 2117
2022
Q3 		$7.22M Sell
331,738
-1,640
-0.5% -$43.2K ﹤0.01% 2218
2022
Q2 		$6.56M Buy
333,378
+13,508
+4% +$316K ﹤0.01% 2330
2022
Q1 		$13.5M Sell
319,870
-19,030
-6% -$804K ﹤0.01% 1950
2021
Q4 		$21.5M Buy
338,900
+177
+0.1% +$10.3K ﹤0.01% 1712
2021
Q3 		$19.9M Buy
338,723
+79,208
+31% +$4.59M ﹤0.01% 1816
2021
Q2 		$12.6M Buy
259,515
+142,014
+121% +$6.17M ﹤0.01% 2218
2021
Q1 		$4.57M Sell
117,501
-4,425
-4% -$266K ﹤0.01% 2812
2020
Q4 		$7.56M Buy
+121,926
New +$5.95M ﹤0.01% 2431

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Northern Trust's KYMR Position: Q2 2026 in Review

Northern Trust increased its Kymera Therapeutics (KYMR) stake by 18% in Q2 2026, buying an estimated $7.52M and bringing the position to 581,907 shares worth $66.7M. The position accounts for 0.01% of the portfolio, ranked #1022.

Northern Trust first reported a position in KYMR in Q4 2020 and has held it in 23 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Northern Trust held 581,907 shares of Kymera Therapeutics worth $66.7M as of Q2 2026.
  • Northern Trust bought 87,468 Kymera Therapeutics shares in Q2 2026, an estimated $7.52M.
  • Kymera Therapeutics made up 0.01% of Northern Trust's portfolio in Q2 2026, its #1022 holding.
  • Northern Trust first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.